Australian Government Department of Industry, Innovation and ScienceThe Australian Government’s Department of Industry, Innovation and Science has oversight for the $250 million Growth Centre Initiative. This industry-led approach is driving innovation, productivity and competitiveness by focusing on areas of competitive strength and strategic priority including Medical Technologies and Pharmaceuticals, Advanced Manufacturing and Cyber Security. This Initiative will help Australia transition into smart, high value and export-focused industries. The department provides policy advice to the Minister for Industry, Innovation and Science.

industry.gov.auAdrian White, Manager Health Technologies Section

adrian.white@industry.gov.au+61 2 6213 7824

These are exciting times for the global medical technology and pharmaceutical (MTP) sector.

Australia has a vibrant MTP sector. Australia boasts over 500 medtech companies and has produced a number of impressive success stories.

It’s also a crucial part of the economy, creating well-paid jobs for smart and skilled Australians across a range of industries.

The Australian Government acknowledges the role of the nation’s MTP sector and what it has to offer to international markets and patients.

We also recognise the importance of encouraging innovation in the sector; after all, it’s innovation that will help Australian MTP companies stay ahead of the pack.

We have given the nation’s MTP sector a shot in the arm, investing $15.6 million in dollar-matched, industry-led projects to boost competitiveness and productivity.

This investment is through MTPConnect, our growth centre established under the government’s $250 million Industry Growth Centres Initiative.

MTPConnect is helping to fund innovative projects that will develop and increase commercialisation of new medical therapies, devices and digital health systems.

CEO’s MessageAustralia is acknowledged as a world leader in the medical technology, biotechnology and pharmaceutical (MTP) sector due to our vibrant research and development environment, strong ecosystem of start-ups, effective and efficient clinical trials landscape, and high-quality research infrastructure and manufacturing companies.

Our sector boasts almost 1,000 companies; has produced numerous global success stories including Cochlear, CSL, Mesoblast, and Nanosonics; and has held a top five spot in the Scientific American’s Worldview biotechnology ranking for the past three years, standing with USA and Singapore.

MTPConnect is an independent, not-for-profit organisation championing a sector-led approach to support the growth of Australia’s flourishing MTP sector, established under the Australian Government’s $250 million Industry Growth Centre initiative.

We are delighted to be leading this delegation of impressive representatives to showcase our thriving ecosystem, and provide attendees of The MedTech Conference with international inroads to our uniquely positioned market to foster innovative, commercial collaborations that will improve the lives of individuals across the globe.

Sue MacLeman Managing Director and CEO, MTPConnect

AU$775million

PUBLIC SPENDING

ON R&D

Ranked TOP 5

in biotech innovation three years running in Scientific American’s

Worldview

World’s 1st electronic pacemakerMark Lidwell, Edgar Booth, Crown St Women’s Hospital

First continuous positive airway pressure (CPAP) machineColin Sullivan, USYDRegarded as today’s “gold standard” in Sleep Apnea treatment

1st bionic ear implantGraeme Clark, Melbourne University

Australian of the Year – Dr Fiona WoodSpray-on-skin / burns treatment

Bionic eye human trialsBionic eye implant for 85% of the clinically blind

50 PHARMA

400 BIOTECH

500 MEDTECH

>100 ASX LISTED

COMPANIES

MARKET VALUE OF ASX LISTED

COMPANIES

AU$4.4billion

JOBS SUPPORTED; 10,000 OF THOSE IN MEDTECH

BIOMEDICAL TRANSLATION FUND

5TOP

AU$85 billion

48,000

AU$4.6billionin manufacturing

EXPORTS

GROSS VALUE ADDED TO THE AUSTRALIAN

ECONOMY

34.4% OF THAT IN MEDTECH

THE AUSTRALIAN MEDTECH SECTOR

IMPORTED

$5.59billion OF GOODS

+ EXPORTED $2.23 billion

OF GOODS IN 2014

GENEROUS GOVERNMENT INCENTIVES

A STRONG CLINICAL TRIALS SECTOR

AU$20 BILLION

MEDICAL RESEARCH

FUTURE FUND

AU$500 million

43.5% refundable R&D TAX OFFSET FOR ELIGIBLE ACTIVITIES

34.4% 43.5%

UP TO

jobs supported

JOBS SUPPORTED ~6,900

AU$630millionINDUSTRY SPENDING

ON R&DSource: Medical Technology Association of Australia

1926

1978

1981

2005

2016

Australian

MEDTECH TIMELINE

AU$1.1 billion

1,360 clinical trials

STARTED IN 2015

GROSS EXPENDITURE

ON

ongoing trials IN 2015

The vibrant

Australian medical

technology, biotechnology

and pharmaceutical

sector

MTPConnectMTPConnect is an independent, not-for-profit organisation championing a sector-led approach to support the growth of Australia’s flourishing medical technology, biotechnology and pharmaceutical ecosystem. MTPConnect can bridge the international gap by connecting international and Australian companies and researchers to foster collaboration and product development, sharing of expertise and best practice, and access to joint funding through grants and investment.

mtpconnect.org.auAlfredo Martinez-Coll, General Manager Stakeholder Engagement

alfredo.martinez-coll@mtpconnect.org.au+61 404 014 686

AustradeThe Australian Trade and Investment Commission – Austrade – contributes to Australia’s economic prosperity by helping Australian businesses to develop international markets and win productive foreign direct investment. Austrade provides information and advice to help Australian exporters to reduce the time, cost and risk of exporting. Austrade is the national point-of-contact for investment enquiries. Working in partnership with Australian state and territory governments, Austrade can provide US companies with information and industry and government contacts needed to establish or expand a business in Australia.

BioMelbourne NetworkBioMelbourne Network is a not-for-profit, industry-led membership association for organisations engaged in biotechnology, medical technology, pharmaceuticals and health innovation in the state of Victoria.

Playing a critical role in connecting business, research, finance and government, BioMelbourne Network supports and promotes the growth of the sector to facilitate the development and commercialisation of new drugs, devices, diagnostics and digital health technologies in Melbourne.

austrade.gov.auGareth Simpson, Trade and Investment Commissioner and Medtech Team Leader, Austrade New York

gareth.simpson@austrade.gov.au

BioMelbourne.org

lsq.com.auMario Pennisi mpennisi@lsq.com.au

MTAA.org.au

AusBiotechAusBiotech is Australia’s life sciences organisation, advancing its members and promoting the commercialisation of Australian life sciences in the national and international marketplace. AusMedtech, part of AusBiotech, is the national industry group for the medical devices and diagnostics sector. Fostering links between industry, research and government, it leads industry advocacy and is represented by a range of advisory committees and expert panels to facilitate the commercial development of the Australian medical devices and diagnostics sector.

Life Sciences Queensland LimitedRepresenting over 170 Member entities, Life Sciences Queensland Limited (LSQ) is an Australian peak industry group, working to assist the growth of individual firms and organisations, and build the profile, capacity and capability of the sector to ensure long term economic, social and environmental benefits to Australia. By highlighting the key role that life sciences innovation plays to feed, fuel and heal our citizens, the major focus of LSQ is to facilitate the future growth and sustainability of Australia’s life sciences industry and enhancing Queensland’s national and international reputation as a key centre of commercial and research excellence and innovation in life sciences.

AusBiotech.org

Connect with the Australian MTP sectorMinister’s Message

AustraliaPavillion

MTPCONNECT.ORG.AU

#GdayMedTech #AusMedTech #MTPConnect

MTPCONNECT.ORG.AU

#GdayMedTech #AusMedTech #MTPConnect

Further information about the Industry Growth Centres Initiative is available at www.business.gov.au/industrygrowthcentres

CONTACT US FOR FURTHER

INFORMATION

Join the conversation: @MTPConnect_AUS #MTPConnect #AusInnovation

MTPConnect

Head Office New Horizons BuildingMonash University20 Research WayClayton VIC 3168

NSW Sydney Hub Level 5J12 School of ITUniversity of Sydney1 Cleveland StreetDarlington NSW 2006

SA Adelaide Hub Medical Device Research Institute Flinders University1284 South RoadClovelly Park SA 5042

The Industry Growth Centres are an Australian Government initiative MTPCONNECT.ORG.AUEmail info@mtpconnect.org.au Phone +61 3 9905 1753

Booth 127 ANDHealthANDHealth is a national digital health initiative funded by a consortium of industry leaders and government partners to facilitate and support the commercialisation of clinically validated digital health technologies. ANDHealth works with mid-stage digital health companies in the areas of commercial and clinical validation, investment readiness and market entry - with a specific focus on technologies which change the diagnosis, prevention, treatment and/or management of chronic and acute conditions for the benefit of the patient.

MTAAThe Medical Technology Association of Australia (MTAA) is the national association representing 71 companies in the medical technology industry. The MTAA’s aims of ensuring the benefits of modern, innovative and reliable medical technology are delivered effectively is paramount to providing better health outcomes to the Australian community.

ANDHealth.com.au

We’re also helping to support innovation and growth in the sector through programs like the Biomedical Translation Fund, Medical Research Future Fund, Biotech Horizons program and the R&D Tax Incentive.

The R&D Tax Incentive program supports more than 1200 medical, health and life science businesses to invest over $1.5 billion in R&D annually.  

Through the $500 million Biomedical Translation Fund, the government is jointly promoting commercialisation with the sector.

The Medical Research Future Fund, including its bespoke Biotech Horizon programme, is currently at more than $7 billion and is scheduled to reach its target of $20 billion in 2020-21.

Congratulations to the delegation from MTPConnect for helping to showcase Australia’s talent and assist businesses with international growth.

The MedTech Conference is the largest and the most important medtech conference in North America.

The government understands the importance of international collaboration and knowledge sharing—and this conference will provide ample opportunities to do both.

Senator the Hon. Arthur Sinodinos Minister for Industry, Innovation and Science Senator for New South Wales

ARC Training Centre in Biodevices (Bioreactor Program) – Swinburne University of TechnologyThe ARC Training Centre in Biodevices aims to develop the next generation of industry-ready researchers and leaders in the medical device industry. We work in collaboration with various industry partners, focusing on identifying and implementing best practices for global competitiveness in MedTech product innovation, including opportunity identification, product design and development, quality systems, manufacturing processes and firm organisation and management.

Bionic Vision TechnologiesBionic Vision Technologies is dedicated to developing effective and innovative implantable retinal prostheses (“bionic eyes”) for patients who have lost vision due to Retinitis Pigmentosa. Our approach is based on proven technology and data from early prototype investigations that form part of our core product pipeline. BVT aims to establish itself as one of the global leaders in the retinal prosthesis market by providing patients with increased independence and enhanced quality of life.

ArtesianArtesian is an Australian early stage venture capital fund manager and manages Australia’s first seed stage medical technology fund known as “the Actuator Fund”.  The fund will invest in early stage medical technology startups drawing from Australia’s world renowned medical expertise.

Blue CurveBlue Curve are medical device design & safety engineering experts, working exclusively with medical devices. From lab bench to market, having a specialist focus allows us to go deep with your product. To get safety and registration right. First time - because it matters. Blue Curve provide expertise across the medical product lifecycle – product & development planning, verification, risk, safety, validation and manufacturing transfer. FDA-CE-TGA-ISO-IEC standards are our world. Your product approved and on the market!

ide Groupide Group creates meaningful products that change lives, grow new organizations and build better futures. ide partners with like-minded organisations and invests in new technologies to create new businesses around intellectual property. Since 2003, ide has grown over 70 organisations and realised over 250 projects across the medical technology landscape, including respiratory care, drug delivery, radiology, radiotherapy and point of care diagnostics. Driven by the hope to make a difference, ide helps bring complex projects to life through creativity, discipline and grit.

HydrixHydrix provides specialised Class III and Class II Medical Device development services to clients around the world.  From feasibility and development planning through to verification and transfer to manufacture. The Hydrix in-house team includes: Project Management, Regulatory, Quality, Human Factors Engineering, Industrial Design, Mechanical, Electronics and Software engineering, and Test engineering, operating within our ISO13485 QMS. All IP generated is transferred to our clients.

Mobius Medical Pty LtdMobius Medical is a full service, ISO 9001 certified Australian CRO established in 2008 providing outstanding clinical trial management and electronic data capture (EDC) services throughout Australia. Mobius Medical successfully manages a variety of first-in-human/early feasibility medical device as well as phase I -II pharmaceutical trials. Pivotal medical device and phase III pharmaceutical trials also make up our portfolio. Mobius Medical provides affordable Electronic Data Capture (EDC) solution compliant with GCP, FDA and EMEA requirements.

Prime Accounting and Business Advisory Pty LtdPrime is an accounting firm that has assisted companies obtain in excess of $250 million in R&D cash refunds for their R&D activities in and outside Australia. We work with start-up, growth businesses and venture capital backed enterprises maximise R&D rebates by obtain overseas findings, providing advice on establishing Australian companies and managing the ongoing accounting and compliance support.

Life Whisperer DiagnosticsThe Life Whisperer team have developed an AI-driven platform for medical diagnosis applications. In the fertility sector, Life Whisperer uses AI to better select healthy embryos for IVF, and ultimately improve outcomes for couples wanting to have children. Life Whisperer will be delivered to IVF clinics globally via a cloud-based system that is non-invasive, does not require costly hardware or process change, will standardise embryo selection, and enables data collection and annotation for clinics.

Movendo Pty Ltdmovendo is an engineering consultancy active in the planning, community building and health sectors. We stand at the crossroads of technology, ecology and culture. We believe that active travel must be the fundamental design element of human systems. We support the diversity of relationships between people and encourage their interactions with nature and the built environment for the realisation of sustainable outcomes. We collaborate with leading health sector organisations to develop user-centred personalized interventions and technologies.

Paul L Clark and AssociatesPaul L Clark and Associates offers an expansive range of Regulatory, Clinical, Quality Management & Commercial services for medical device companies marketing their products in Australia & New Zealand covering the Australian Register of Therapeutic Goods (ARTG); sponsorship for international companies selling into Australia; liaison with the Therapeutic Goods Administration (TGA); and commercial services. Our network spans a wide range of regulatory/clinical/market research/reimbursement experts, CROs, clinical trial sites/investigators, test labs, R&D organizations, legal and accounting resources.

swinburne.edu.au/research/biodevicesProfessor Paul Stoddart, Director pstoddart@swin.edu.au+61 3 9214 5839

bionicvis.comJulie Anne Quinn info@bionicvis.com+61 438 939 710

artesianinvest.com Richard Case richard@artesianinvest.com+61 409 355 363

bluecurve.com.auTom Stamp, Director tom@bluecurve.com.au+61 407 093 364

idegroup.com.au / idegroupinc.com George Sidis george@idegroup.com.au+1 718 536 8541

hydrix.comRichard Stephens Richard.stephens@hydrix.com+61 407 290 226

mobiusmedical.com.auStefan Czyniewski stefan@mobiusmedical.com.au+61 414 669 565

primefinancial.com.auSimone Quin, Partner simoneq@primefinancial.com.au

lifewhisperer.coDr Michelle Perugini michelle@lifewhisperer.co+61 412 396 960

movendo.com.auJose Mantilla, Director jose.mantilla@movendo.com.au+61 499 888 081

paullclarkandassociates.comPaul L Clark, President pclark@paullclarkandassociates.com+61 425 108 107 / +1 978 743 6525

ClevertarClevertar is an award-winning Australian digital health company that brings behavior changing ‘relational agents’ to healthcare. The company was born out of research showing that autonomous virtual characters influence human behavior similar to a human interaction, and recent developments enable this to be achieved at a fraction of the cost. Based on this research, Clevertar has developed a SaaS platform for digital health coaching, focusing on chronic condition self-management and hospital avoidance.

CSIRO Biomedical EngineeringCSIRO is Australia’s premier government research organisation. The CSIRO Biomedical Manufacturing Program engages with companies in the medtech and biotech industry to develop innovative products and new manufacturing processes, improving productivity and efficiency, to assist them in their growth strategies. The key science capabilities in the Program include: synthetic organic and medicinal chemistry, polymer science, flow chemistry, protein engineering and fermentation, structural biology, cell biology and biocompatibility, and computational modelling.

goAct Pty. Ltd. goAct facilitates data driven action for improved heath process and care models. It aggregates and connects health information through secure, smart device data feeds and a broad range of other sources. It enables multi-factorial insights across the diverse determinants of health. It assists you to visualise data, helps with predictive analysis - machine learning - and enables establishing ongoing process improvement - positive healthy feedback loops.

Ellex MedicalEllex Medical Lasers is an Australia-based company that is engaged in the business of designing, manufacturing and marketing a line of lasers used by ophthalmologists. Ellex manufactures and sells photodisruptors, photocoagulators and selective laser trabeculoplasty system for treating cataract, retina and glaucoma conditions.

CenofexCenofex Innovations is an early stage medical device company using a proprietary technology to treat lymphedema. Caused by a poorly functioning lymphatic system, lymphedema is a debilitating, life-long condition characterised by the painful swelling of a limb or body region. By employing ultrasound in a novel way to move fluids, Cenofex aims to revolutionize lymphedema treatment with a device that achieves effective clinical results, while delivering a better patient experience, at a much lower cost.

Graeme Clark Institute for Biomedical Engineering, University of Melbourne The Graeme Clark Institute for Biomedical Engineering promotes and coordinates the extensive biomedical engineering activities that exist across The University of Melbourne, drawing on emerging scientific, medical and engineering approaches to drive transformative clinical solutions. The Graeme Clark Institute partners with healthcare and research organisations, industry and government to solve today’s challenges and develop new technologies for tomorrow. We work with our partners to translate research into innovations that leads to improved health outcomes.

PROHAB™We believe in thinking differently and leading rehabilitation. PROHAB™ in collaboration with University partners and Elite Sport is breaking new ground in advanced manufacturing and artificial intelligence software. PROHAB™ is an Australian company who cares about making the best rehabilitation devices and services for Professional Sport, Healthcare, Fitness and Home Health. Want to partner with us?

The Actuator – Australia’s National MedTech Accelerator

Australia’s first national medtech accelerator deploys a dynamic, integrated suite of programs that support rapid transformation of new ideas into medtech solutions. With an exclusive venture fund and strategic partnerships, The Actuator accelerates medtech startups from seed to series A with multiple capital injections, talented creativity and comprehensive global domain expertise - through industry leadership and investor connectivity. The Actuator is also home to Australia’s leading national medtech entrepreneurship competition - MedTech’s Got Talent.

Cook Medical AustraliaCook Australia manufactures a diverse range of medical products for its home customers and for COOK distributors and subsidiaries around the world. Originally focused on angiographic and interventional devices, the company’s concentration has expanded to include other items, particularly those needed for use with in vitro fertilization and assisted reproduction procedures.

TechInSATechInSA works with the South Australian high-tech sector to facilitate commercialisation and growth. The agency administers the South Australian Early Commercialisation Fund, providing early stage companies and entrepreneurs up to $500,000 for eligible projects. It also provides business and marketing assistance and manages two business facilities based at the Thebarton Hi-Tech Precinct. TechInSA is the South Australian Government’s innovation agency.

Elementary LawElementary Law provides a full scope of legal services including intellectual property (IP), funding, research and commercialisation of technologies. With strong expertise in negotiating deals (throughout Australia and worldwide) we assist companies to access high level expertise with direct, pragmatic, timely and cost-effective legal advice. Our Principal, Jason Watson, has been named “a major player with a significant reputation” by Intellectual Asset Management (IAM Patent 1000 – The World’s Leading Patent Professionals).

clevertar.comTanya Newhouse tanya.newhouse@clevertar.com+61 424 079 615

goAct.com.auDr Simon Divecha simon@goAct.com.au

ellex.comTom Spurlingtspurling@ellex.com

cenofex.comSheridan Gho sheridan.gho@cenofex.com+1 707 639 3613

csiro.auPaul Savage paul.savage@csiro.au+61 407 357 776

clarkinstitute.unimelb.edu.auDr Jia-Yee Lee, Director, Industry Engagement jia-yee.lee@unimelb.edu.au

prohab.aiLyndon Huf, CEO lhuf@prohab.ai+61 400 270 274

medtechactuator.commedtechchallenge.comDr Buzz Palmer, CEO & Executive Director buzz@medtechactuator.com

cookmedical.com

techinsa.com.auHerve Astier herve.astier@techinsa.com.au+61 8 8217 6400

elementarylaw.com.au Jason Watson jason.watson@elementarylaw.com.au+61 409 097 869

Anatomics IncAnatomics is a privately held Australian medical device company that has been manufacturing and marketing surgical products to surgeons locally and internationally since 1996. Anatomics was one of the first companies around the world to use medical imaging and 3D printers to manufacture medical devices. Anatomics developed the technology; investing in software design, implant manufacture and material testing. The company now exports custom and “off the shelf” implants to over 20 countries around the world.

Analytica LtdAnalytica is the manufacturer of PeriCoach®, an e-health solution for Stress Urinary Incontinence, affecting millions of women globally. PeriCoach includes a device, an app to guide proper performance of pelvic muscle exercises, and a portal connection for patient management by a clinician. PeriCoach has regulatory clearance in Australia, CE mark and USFDA 510(k) clearance, and is available for sale in Australia, New Zealand, United Kingdom, Ireland, and the USA.

anatomics.comDean Carson, Vice-President US Operations

dean.carson@anatomics.com+1 (415) 806-2599

analyticamedical.com Megan Henken mhenken@analyticamedical.com+1 (720) 403-3344

Australia Pavillion

M T P C O N N E C T. O R G . A U

DELEGATES

CONTACT US FOR FURTHER

INFORMATIONFurther information about the Industry Growth Centres Initiative is available at www.business.gov.au/industrygrowthcentres

Head Office New Horizons BuildingMonash University20 Research WayClayton VIC 3168Australia

NSW Sydney Hub Level 5J12 School of ITUniversity of Sydney1 Cleveland StreetDarlington NSW 2006Australia

SA Adelaide Hub Medical Device Research Institute Flinders University1284 South RoadClovelly Park SA 5042Australia

#GdayMedTech #AusMedTech #MTPConnect

Join the conversation: @MTPConnect_AUS #MTPConnect #AusInnovation

MTPConnect

The Industry Growth Centres are an Australian Government initiative

M T P C O N N E C T. O R G . A UEmail info@mtpconnect.org.auPhone +61 3 9905 1753